scholarly journals Supralevator Total Pelvic Exenteration Without Colostomy — Case Report

2017 ◽  
Vol 2 (3) ◽  
pp. 258-261
Author(s):  
Marian Botoncea ◽  
Claudiu Molnar Varlam ◽  
Adrian Chiujdea ◽  
Călin Molnar
Keyword(s):  
Case Report ◽  
Pelvic Exenteration ◽  
Percutaneous Nephrostomy ◽  
Total Pelvic Exenteration ◽  
Extensive Resection ◽  
Reconstruction Process ◽  
Recurrent Cervical Cancer ◽  
Pelvic Malignancies ◽  
Pelvic Cancer

Abstract Background: Pelvic exenteration is an ultra-radical surgical procedure described by Brunschwig in 1948, which attempts to surgically cure patients with recurrent pelvic cancer after radiotherapy. Several variants of pelvic exenteration are described that allow a more limited or extensive resection, depending on the stage of the disease. Case report: We report the case of a 54-year-old woman, who was diagnosed with a tumoral rectovaginal fistula after a recurrent cervical cancer that had been treated with a total hysterectomy with bilateral adnexectomy and a left percutaneous nephrostomy, as well as interaortocaval lymph node resection. The patient had undergone a supralevator total pelvic exenteration with pelvic and interaortocaval lymphadenectomy. The reconstruction process included right ureterostomy, left nephrostomy, and colocutaneous anal anastomosis (Parks procedure). Conclusions: Supralevator total pelvic exenteration provides hope for cure in patients with pelvic malignancies that reappear after radiotherapy. The restoration of the digestive tract and avoiding colostomy with a colocutaneous anastomosis increases the quality of life in these cases.

scholarly journals Long Term Survival After Total Pelvic Exenteration In A Patient With Recurrent Cervical Carcinoma: A Case Report

2014 ◽  
Vol 11 (3) ◽  
pp. 186-188
Author(s):  
Soner Düzgüner ◽  
Tuba Zengin ◽  
Tolga Taşçı ◽  
Taner Turan ◽  
Nurettin Boran ◽  
...  
Keyword(s):  
Case Report ◽  
Cervical Carcinoma ◽  
Pelvic Exenteration ◽  
Total Pelvic Exenteration ◽  
Term Survival ◽  
Long Term Survival

scholarly journals Why are recurrent cervical cancers of the pelvic stump misdiagnosed as interstitial cystitis?: The urologist’s point of view based on a case report

2013 ◽  
Vol 7 (5-6) ◽  
pp. 359
Author(s):  
Jin Kyu Oh ◽  
Khae-Hawn Kim
Keyword(s):  
Interstitial Cystitis ◽  
Lower Abdominal Pain ◽  
Percutaneous Nephrostomy ◽  
Punch Biopsy ◽  
Point Of View ◽  
Stent Insertion ◽  
Recurrent Cervical Cancer ◽  
Original Specimen ◽  
Leiomyoma Of The Uterus

A 50-year-old female who had undergone laparoscopic total hysterectomy at a local clinic owing to leiomyoma of the uterus was referred to our hospital after having dysuria, urgency, frequency, lower abdominal pain and right flank pain over several months. After routine examinations, cystoscopy, computed tomography and magnetic resonance imaging were performed, and non-ulcerative interstitial cystitis accompanied by post-operative fibrosis secondary to a previous surgery was suggested. Pentosan sulfuric polyester(Elmiron®) reduced her severely debilitating symptoms and improved her quality of life. Both the hydronephrosis and the symptoms were relieved by ureteral stent insertion and percutaneous nephrostomy. However, a few days later, she presented with vaginal bleeding along with her previous symptoms, and punch biopsy of the vaginal stump resulted in a diagnosis of adenocarcinoma. Both ureterocutaneostomy with radical cystectomy and lower anterior resection for rectum invasion were conducted. After the slide review of the original specimen from the local clinic, she was diagnosed with recurrent cervical cancer of the vaginal stump.

scholarly journals Robotic Total Pelvic Exenteration with Laparoscopic Rectus Flap: Initial Experience

2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
Brian R. Winters ◽  
Gary N. Mann ◽  
Otway Louie ◽  
Jonathan L. Wright
Keyword(s):  
Blood Loss ◽  
Open Surgery ◽  
Pelvic Exenteration ◽  
Locally Advanced ◽  
Descriptive Statistics ◽  
Initial Experience ◽  
Total Pelvic Exenteration ◽  
Surgical Morbidity ◽  
Pelvic Malignancies ◽  
Estimated Blood Loss

Total pelvic exenteration is a highly morbid procedure performed for locally advanced pelvic malignancies. We describe our experience with three patients who underwent robotic total pelvic exenteration with laparoscopic rectus flap and compare perioperative characteristics to our open experience. Demographic, tumor, operative, and perioperative factors were examined with descriptive statistics reported. Mean operative times were similar between the two groups. When compared to open total pelvic exenteration cases(n=9), median estimated blood loss, ICU stay, and hospital stay were all decreased. These data show robotic pelvic exenteration with laparoscopic rectus flap is technically feasible. The surgery was well tolerated with low blood loss and comparable operative times to the open surgery. Further study is needed to confirm the oncologic efficacy and the suggested improvement in surgical morbidity.

scholarly journals DIFFUSE INFIL TRATIVE CARCINOMA OF THE RECTUM IN A YOUNG ADULT RESECTED BY TOTAL PELVIC EXENTERATION -A CASE REPORT-

1991 ◽  
Vol 52 (6) ◽  
pp. 1313-1318
Author(s):  
Hiroto AKIYAMA ◽  
Syunpei YOKOI ◽  
Masayasu SUZUKI ◽  
Noriji NIINOMI ◽  
Yoshihiko TORII ◽  
...  
Keyword(s):  
Case Report ◽  
Young Adult ◽  
Pelvic Exenteration ◽  
Total Pelvic Exenteration ◽  
Carcinoma Of The Rectum

Resection of recurrent cervical cancer after total pelvic exenteration

2007 ◽  
Vol 17 (1) ◽  
pp. 137-140 ◽  
Author(s):  
S. M. Mourton ◽  
Y. Sonoda ◽  
N. R. Abu-Rustum ◽  
B. H. Bochner ◽  
R. R. Barakat ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Median Time ◽  
Pelvic Exenteration ◽  
Femoral Nerve ◽  
Psoas Muscle ◽  
Total Pelvic Exenteration ◽  
Recurrent Cervical Cancer ◽  
Time To Recurrence ◽  
Initial Recurrence ◽  
Alive With Disease

The objective of this study was to describe the management of patients with recurrent cervical cancer after total pelvic exenteration (TPE). We reviewed the records of patients who underwent TPE for recurrent cervical cancer between June 1992 and December 2003 and subsequently developed recurrent disease. Thirty-seven patients underwent TPE during the study period, and 25 (68%) subsequently developed recurrence proven by radiographic and/or biopsy studies. Recurrence sites included pelvic (12), inguinal (5), retroperitoneal (5), hepatic (4), vulva (2), perineum (1), transposed ovary (1), and lung (1). The median time to recurrence was 7 months (range 2–73 months), with 92% (23/25) occurring within 2 years of TPE. Management of recurrence was known in 21 of 25 patients, which included chemotherapy (10), surgical resection (7), and no further treatment (4). Surgically resected recurrences were isolated to the groin (2), vulva (2), perineum (1), transposed ovary (1), and psoas muscle (1). The four patients who underwent ovarian, perineal, and vulvar resections succumbed to their disease in a median time of 13 months (range 2–21 months). Of the two patients with surgically resected groin recurrences, one is alive with disease 21 months after initial recurrence and the other is alive without evidence of disease 85 months later. One patient had an isolated 4-cm recurrence involving the psoas muscle and the femoral nerve and is without the evidence of disease 9 months later. Resection of isolated recurrences after TPE is a reasonable option in selected patients, particularly in those with solitary inguinal metastases

Sign in / Sign up

Export Citation Format

Share Document